Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: Clinical Outcomes and Ejaculatory Function in BPO Patients Treated With Silodosin

View source ↗

Summary

This clinical trial registry entry describes a study evaluating clinical outcomes and ejaculatory function in patients with benign prostatic obstruction treated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rapaflo (silodosin)

Snippet

Sponsor: Marmara University | Conditions: Benign Prostate Obstruction (BPO), Lower Urinary Tract Symptom | Status: NOT_YET_RECRUITING